ABT Abbott Laboratories PE ratio, current and historical analysis
The current PE ratio for Abbott Laboratories stock as of Feb 21, 2025 is 40.88. This is calculated based on the current EPS of $3.3 and the stock price of $134.92 per share. The P/E ratio has an increase of 20% from the past four quarters average of 34.0.
ABT PE ratio history
The average historical PE ratio of Abbott Laboratories for the last ten years is 50.54. The current PE ratio of 40.88 is 19% below the historical average. Over the past ten years, ABT's PE ratio was at its highest in the Mar 2018 quarter at 230.46, when the stock price was $59.92 and the EPS was $0.26. The lowest value was in the Sep 2015 quarter, when it reached 13.27 with a price of $40.22 and an EPS of $3.03.
Abbott Laboratories PE ratio by year
Maximum annual increase: 417.3% in 2017
Maximum annual decrease: -74.46% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2023 | 33.56 | 20.42% | $110.07 | $3.28 |
| 2022 | 27.87 | -21.38% | $109.79 | $3.94 |
| 2021 | 35.45 | -18.41% | $140.74 | $3.97 |
| 2020 | 43.45 | 3.55% | $109.49 | $2.52 |
| 2019 | 41.96 | -22.27% | $86.86 | $2.07 |
| 2018 | 53.98 | -74.46% | $72.33 | $1.34 |
| 2017 | 211.37 | 417.3% | $57.07 | $0.27 |
| 2016 | 40.86 | 167.41% | $38.41 | $0.94 |
| 2015 | 15.28 | -49.08% | $44.91 | $2.94 |
| 2014 | 30.01 | 28.41% | $45.02 | $1.5 |
| 2013 | 23.37 | 34.16% | $38.33 | $1.64 |
| 2012 | 17.42 | -6.14% | $65.5 | $3.76 |
| 2011 | 18.56 | 15.42% | $56.23 | $3.03 |
| 2010 | 16.08 | 10.52% | $47.91 | $2.98 |
| 2009 | 14.55 | -13.85% | $53.99 | $3.71 |
Abbott Laboratories PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2024 | 34.55 | 5.72% | $114.01 | $3.3 |
| Jun 2024 | 32.68 | -7.13% | $103.91 | $3.18 |
| Mar 2024 | 35.19 | 4.86% | $113.66 | $3.23 |
| Dec 2023 | 33.56 | 2.22% | $110.07 | $3.28 |
| Sep 2023 | 32.83 | -11.17% | $96.85 | $2.95 |
| Jun 2023 | 36.96 | 20.82% | $109.02 | $2.95 |
| Mar 2023 | 30.59 | 9.76% | $101.26 | $3.31 |
| Dec 2022 | 27.87 | 28.73% | $109.79 | $3.94 |
| Sep 2022 | 21.65 | -3.73% | $96.76 | $4.47 |
| Jun 2022 | 22.49 | -17.35% | $108.65 | $4.83 |
| Mar 2022 | 27.21 | -23.24% | $118.36 | $4.35 |
| Dec 2021 | 35.45 | 21.82% | $140.74 | $3.97 |
| Sep 2021 | 29.1 | -10.38% | $118.13 | $4.06 |
| Jun 2021 | 32.47 | -13.3% | $115.93 | $3.57 |
| Mar 2021 | 37.45 | -13.81% | $119.84 | $3.2 |
ABT average PE ratio chart
ABT's current P/E ratio is above the 3 and 5-year historical averages, but it is below the 10-year average.
ABT PE vs peers
Compared to its peer BSX, ABT's PE ratio stands lower, however it is higher than JNJ's and AZN's. Abbott Laboratories's PE ratio is trading above the peer group average of 34.52.
| Stock name | PE ratio | Market cap |
|---|---|---|
| NVS Novartis AG | 18.47 | $215.98B |
| HOLX Hologic Inc | 20.22 | $14.47B |
| MDT Medtronic plc | 27.34 | $115.33B |
| JNJ Johnson & Johnson | 27.79 | $390.76B |
| TMO Thermo Fisher Scientific Inc | 32.12 | $200.91B |
| AZN Astrazeneca plc | 32.7 | $230.16B |
| PFE Pfizer Inc | 34.61 | $149.04B |
| ABT Abbott Laboratories | 40.88 | $234.01B |
| BSX Boston Scientific Corp | 82.93 | $154.2B |
| BMY Bristol Myers Squibb Co | N/A | $113.3B |
Frequently asked questions
What is Abbott Laboratories's PE ratio?
As of Feb 21, 2025, ABT stock has a price to earnings ratio of 40.88.
What is the 3-year average PE ratio for Abbott Laboratories (ABT)?
The average PE ratio for ABT stock over the past 3 years is 30.51.
What is the 5-year average PE ratio for Abbott Laboratories (ABT)?
The average PE ratio for ABT stock over the past 5 years is 34.85.
What is the highest PE ratio for ABT?
Over the last ten years, the quarterly PE ratio reached a historic high of 230.46 in the Mar 2018 quarter.
How does the current PE ratio for ABT compare to its historical average?
The current price to earnings ratio of ABT is 19% lower than the 10-year historical average.
How is ABT's PE ratio calculated (Abbott Laboratories PE ratio formula)?
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Feb 21, 2025), Abbott Laboratories's stock price is $134.92. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $3.3. Therefore, Abbott Laboratories's P/E ratio for today is 40.88. PE RATIO(40.88) = STOCK PRICE($134.92) / TTM EPS($3.3)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.